Search All News
By participating in one of the world’s largest genetic studies, New Yorkers will help bring precision medicine to their communities, Columbia’s David Goldstein explains.
Among teens treated in an emergency department for drug-related symptoms, nearly 20% who used Spice, K2, or other synthetic cannabinoids experienced seizures.
- August 27, 2018
A new study led by Columbia's Mathew Maurer found that tafamidis reduced deaths from transthyretin amyloid cardiomyopathy, a type of heart failure.
- August 24, 2018
Columbia University biomedical researchers have captured close-up views of a skin-cell protein that plays important roles in sensing temperature, itch, and pain.
- August 21, 2018
A Mailman study of more than 1 million pregnancies in Finland reports that prenatal exposure to elevated levels of DDT is associated with an increased risk for autism.
- August 13, 2018
Letters written to frequent prescribers of Seroquel, which can cause harmful side effects in the elderly, significantly reduced the number of prescriptions for Medicare patients.
- August 8, 2018
A new way to conduct health studies by tapping the troves of data held in electronic health records may speed medical research and reduce the frequency of conflicting findings.
- August 2, 2018
A new clinical trial suggests that donepezil does not improve cognitive performance in people with mild cognitive impairment who also have clinical depression.
- July 30, 2018
Columbia researchers found that a gene associated with an autoimmune form of hair loss could be activated to improve cancer immunotherapy.
- July 27, 2018
A new National Academies report—co-authored by Columbia Nursing’s Suzanne Bakken—recommends returning health information gathered during research to study participants.